Name | Sector |
Revenue
$mlns |
M&A Activity | Last 5 Years | ||
---|---|---|---|---|---|---|
Total | Buy | Sell | ||||
Collegium Pharmaceutical
NASDAQ : COLL Stoughton, Massachusetts, United States website |
Life Science | 567 | 3 | 3 | - |
|
Repligen
NASDAQ : RGEN Waltham, Massachusetts, United States website |
Life Science | 639 | 12 | 11 | 1 |
|
Amylyx
Public Cambridge, Massachusetts, United States website |
Life Science | - | 1 | 1 | - |
|
NASDAQ : BIIB Cambridge, Massachusetts, United States website |
Life Science | 9,836 | 10 | 9 | 1 |
|
Vertex Pharmaceuticals
NASDAQ : VRTX Boston, Massachusetts, United States website |
Life Science | 9,869 | 10 | 8 | 2 |
|
Ginkgo Bioworks
NYSE : DNA Boston, Massachusetts, United States website |
Life Science | - | 15 | 14 | 1 |
|
Tectonic Therapeutic
NASDAQ : AVRO Cambridge, Massachusetts, United States website |
Life Science | - | 1 | 1 | - |
|
Spyre Therapeutics
NASDAQ : SYRE Waltham, Massachusetts, United States website |
Life Science | 1 | 1 | 1 | - |
|
Ironwood Pharmaceuticals
NASDAQ : IRWD Boston, Massachusetts, United States website |
Life Science | 443 | 1 | 1 | - |
|
Azenta
NASDAQ : BRKS Chelmsford, Massachusetts, United States website |
Life Science | 514 | 29 | 24 | 5 |
|
Charles River Laboratories International
NYSE : CRL Wilmington, Massachusetts, United States website |
Life Science | 4,129 | 33 | 31 | 2 |
|
Aprea Therapeutics
NASDAQ : APRE Boston, Massachusetts, United States website |
Life Science | - | 1 | 1 | - |
|
Intellia Therapeutics
NASDAQ : NTLA Cambridge, Massachusetts, United States website |
Life Science | 36 | 1 | 1 | - |
|
Blueprint Medicines
NASDAQ : BPMC Cambridge, Massachusetts, United States website |
Life Science | 249 | 1 | 1 | - |
|
KALA BIO
NASDAQ : KALA Arlington, Massachusetts, United States website |
Life Science | 4 | 2 | 1 | 1 |
|
Zenas BioPharma
Public Waltham, Massachusetts, United States website |
Life Science | 50 | 1 | 1 | - |
|
We built Mergr to save people the arduous and time-consuming process of tracking when companies are bought, sold, and who currently owns them.
Every day, new opportunities emerge around M&A and we help professionals of all types comb through transactions, investors, and corporate acquirers via an easy-to-use web database that is accessible to anyone.
Try us for 1 week free today!
No obligation. Cancel anytime.